Glycyrrhiza glabra
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Glycyrrhiza glabra
- Accession Number
- DB14312
- Description
Glycyrrhiza glabra is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Approved, Experimental
- Synonyms
- Ae-licorice
- Cultivated Licorice Root
- Gan Cao Root
- Gancao (Glycyrrhiza Glabra)
- Glycyrrhiza
- Glycyrrhiza (Glycyrrhiza Glabra)
- Glycyrrhiza Glabra (Licorice) Rhizome/root
- Glycyrrhiza Glabra (Licorice) Rhizome/root Extract
- Glycyrrhiza Glabra (Licorice) Root
- Glycyrrhiza Glabra (Licorice) Root Extract
- Glycyrrhiza Glabra (Licorice) Root Powder
- Glycyrrhiza Glabra Extract
- Glycyrrhiza Glabra L Rhizome Extract
- Glycyrrhiza Glabra Processed Root
- Glycyrrhiza Glabra Rhizome
- Glycyrrhiza Glabra Root
- Glycyrrhiza Glabra Root Powder
- Glycyrrhiza Glabra Root With Rhizome
- Glycyrrhiza Glandulifera Root
- Glycyrrhiza Hirsuta Root
- Glycyrrhiza Pallida Root
- Glycyrrhiza Violacea Root
- Glycyrrhizae Radix Et Rhizoma (Glycyrrhiza Glabra)
- Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle (Glycyrrhiza Glabra)
- Guang Guo Gan Cao Root
- Licorice Allergenic Extract
- Licorice Extract
- Licorice Extract Powder
- Licorice Flavanoid Oil
- Licorice Rhizome/root Extract
- Liquiritiae Radix
- Liquorice Root (Glycyrrhiza Glabra)
- Prepared Liauorice Root (Glycyrrhiza Glabra)
- Russian Licorice Root
- Spanish Licorice Root
- Turkish Licorice Root
- Yashtimadhu Root
- Zhigancao (Glycyrrhiza Glabra)
Pharmacology
- Indication
- Not Available
- Associated Conditions
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Bronchozone Cough Syrup Certified Glycyrrhiza glabra (0.012 ml) + Ammonium carbonate (30 mg) + Ammonium chloride (42 mg) + Levomenthol (0.31 mg) + Polygala senega root (0.015 ml) Syrup Oral D.C. Labs Limited 1951-12-31 2003-07-11 Canada 
C Ottways Lax Tab Glycyrrhiza glabra (28 mg) + Aloe Vera Leaf (132 mg) + Capsicum (19 mg) + Frangula purshiana bark (28 mg) + Ginger (9 mg) + Sennosides (28 mg) Tablet Oral C Ottway Herbalist 1950-12-31 1997-06-13 Canada Cennlacs Glycyrrhiza glabra (182 mg) + Sennosides (726 mg) Powder Oral Westward Distributors 1983-12-31 1997-05-30 Canada Herbal Laxative Formula Glycyrrhiza glabra (40 mg) + Frangula purshiana bark (130 mg) + Rhubarb (4 mg) + Sennosides (240 mg) Tablet Oral Wn Pharmaceuticals Ltd. 2004-02-25 2008-07-17 Canada Herbal Laxative Formula Caplet Glycyrrhiza glabra (80 mg) + Frangula purshiana bark (150 mg) + Rhubarb (10 mg) + Sennosides (250 mg) Tablet Oral Health Wise Nutrition Inc. 1995-12-31 2002-07-18 Canada Herbolax Glycyrrhiza glabra (55 mg) + Frangula purshiana bark (65 mg) + Rhubarb (65 mg) + Sennosides (277 mg) Tablet Oral Seroyal International Inc. 1988-12-31 2009-07-06 Canada Laxatex Tab Glycyrrhiza glabra (30 mg) + Frangula purshiana bark (150 mg) + Rhubarb (8 mg) + Sennosides (240 mg) Tablet Oral Carmaran LtÉe 1980-12-31 1996-09-09 Canada Maxclinic Cirmage Lifting Glycyrrhiza glabra (0.01 g/23g) + Adenosine (0.009 g/23g) Stick Topical N&b lab.co.ltd 2016-11-01 2018-12-01 US 
Medi SM 24K Gold Hydrogel Peptide Mask Pack Glycyrrhiza glabra (0.01 g/100g) + Adenosine (0.01 g/100g) + Butylene glycol (0.01 g/100g) + Chlorphenesin (0.01 g/100g) + Chondrus crispus (0.02 g/100g) + Glycerin (0.05 g/100g) + Gold (0.01 g/100g) + Nicotinamide (0.02 g/100g) + Polysorbate 20 (0.01 g/100g) + Polysorbate 60 (0.02 g/100g) + Potassium chloride (0.02 g/100g) + Propolis wax (0.01 g/100g) + Titanium dioxide (0.01 g/100g) + Xanthan gum (0.01 g/100g) Emulsion Topical Mbg Inc (Korea Institute of Science Development) 2017-11-07 2018-11-07 US Stomacare Glycyrrhiza glabra (900 mg) + Elm (100 mg) Tablet Oral Nu Life Nutrition Ltd. 1997-10-20 2000-03-03 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Maxclinic Cirmage Lifting Glycyrrhiza glabra (0.01 g/23g) + Adenosine (0.009 g/23g) Stick Topical N&b lab.co.ltd 2016-11-01 2018-12-01 US Medi SM 24K Gold Hydrogel Peptide Mask Pack Glycyrrhiza glabra (0.01 g/100g) + Adenosine (0.01 g/100g) + Butylene glycol (0.01 g/100g) + Chlorphenesin (0.01 g/100g) + Chondrus crispus (0.02 g/100g) + Glycerin (0.05 g/100g) + Gold (0.01 g/100g) + Nicotinamide (0.02 g/100g) + Polysorbate 20 (0.01 g/100g) + Polysorbate 60 (0.02 g/100g) + Potassium chloride (0.02 g/100g) + Propolis wax (0.01 g/100g) + Titanium dioxide (0.01 g/100g) + Xanthan gum (0.01 g/100g) Emulsion Topical Mbg Inc (Korea Institute of Science Development) 2017-11-07 2018-11-07 US
Categories
- Drug Categories
- Classification
- Not classified
Chemical Identifiers
- UNII
- 2788Z9758H
- CAS number
- 84775-66-6
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Periodontitis, Chronic 1 2, 3 Completed Prevention Antimicrobial Effect / Caries / High Caries Risk Patients / Side Effects 1 1, 2 Completed Treatment Malignant Neoplasm of Pancreas 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Oral 400 mg/100mL Solution Oral 20 mg/5mL Solution Topical 6 g/100mL Syrup Oral Powder Oral Solution Oral 12 mL/100mL Suspension Oral 100 mg/5mL Stick Topical Emulsion Topical Suspension Oral 450 mcL/5mL Syrup Oral 50 mg/5mL Powder, for solution Oral Solution Oral 1.2 mg/5mL Tablet Oral Syrup 5 mg/5mL Syrup 100 mg/5mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on July 05, 2018 11:13 / Updated on June 12, 2020 11:42